THE FDA STRIKES AGAIN: My Brother’s Life-saving Discovery. John Stossel’s brother, the late Dr. Thomas Stossel of Harvard, found a protein in the blood that reduces inflammation and could potentially be a breakthrough in treating many diseases, including Covid-19. A biotech company has spent $50 million to develop a treatment and has demonstrated its safety in humans. But the treatment is still years — and hundreds of millions of dollars — away from receiving FDA approval for patients to try.  The company is hoping the pandemic will prompt the FDA to speed up the process.